S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Somnigroup Finalizes $2.3 Billion Acquisition of Leggett & Platt

Somnigroup International has finalized its all-stock acquisition of Leggett & Platt, a deal valued at approximately $2.3 billion. By integrating the diversified manufacturer into its global portfolio, the bedding company aims to deepen its vertical integration and capture significant operational synergies across its 170-facility manufacturing network.

Somnigroup Finalizes $2.3 Billion Acquisition of Leggett & Platt
Photo: Bio & News

The merger, which grants former Leggett & Platt shareholders roughly 9% ownership of the combined entity, creates a massive industrial footprint spanning 37 countries with a total workforce exceeding 36,000. Somnigroup chairman and CEO Scott Thompson noted that the move secures a critical segment of the supply chain while leveraging Leggett & Platt’s engineering legacy to accelerate innovation. The transaction has already improved Somnigroup's financial position, reducing net leverage by 0.2 times Adjusted EBITDA.

Management has raised its annual run-rate synergy target to $75 million, a $25 million increase from initial projections. While Leggett & Platt will operate as a distinct reporting segment, the company plans to absorb non-cash expenses of roughly $60 million annually tied to fair value adjustments of the acquired business and bonds. Investors can expect a detailed breakdown of the integration strategy during a business update call scheduled for September 2, 2026.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!